AbbVie Inc (ABBV)

AbbVie Inc (ABBV)


Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

AbbVie Inc (ABBV) Profile

AbbVie Inc (ABBV.xnys) is a biopharmaceutical company headquartered in North Chicago, Illinois, America. AbbVie, after the separation from Abbott Laboratories, started operating as a research-based pharmaceutical manufacturer to allow markets to value the two businesses separately. The company is committed to product development in the cystic fibrosis disease area and plans to reduce emissions by 25 per cent by 2025. Abbvie employs 47,000 people in 170 countries across the globe. AbbVie Inc stock (ABBV.xnys) is listed on the New York Stock Exchange (NYSE) and had a $45.80B (USD) market capitalisation as of January 2022. The company announced the acquisition of Soliton Inc at the beginning of 2022 in order to include a proven treatment for the appearance of cellulite. AbbVie has also got approval from the Food and Drug Administration (FDA) for the RINVOQ medicine to treat adults with active psoriatic arthritis and the VUITY medicine, which is the first and only eye drop to treat presbyopia. The second one is a common and progressive eye condition that affects 128M Americans, and its treatment is now available by prescription in pharmacies nationwide.

Holding cost
Long
-5%
Short
-2.5%
Trading hours in US Eastern Time
Fri
16:30-23:00
Mon
16:30-23:00
Tue
16:30-23:00
Wed
16:30-23:00
Thu
16:30-23:00
Sun
Closed
Sat
Closed

Start Trading AbbVie Inc (ABBV)
with a Market Leader Today

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

6 Reasons to Trade Share
CFDs with FP Markets

An Australian-regulated
forex & CFD broker

Go Long or Short

Increase your ability to profit in all market conditions Leverage options up to 20:1

Direct Market Access (DMA) Execution

Real-time, transparent share prices Control, Functionality and deep liquidity Full Market depth & see your orders in the queue

Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with superior client portal

24/5 Multilingual
Customer Support

Award winning support & personal account managers

Global Exposure

Low margins and competitive commission +10,000 products on global stocks across 4 continents

Earn Dividends

On long positions No ownership of physical shares necessary

Start Trading
in Minutes

Open an account now

bullet Access 10,000+ financial instruments
bullet Auto open & close positions
bullet News & economic calendar
bullet Technical indicators & charts
bullet Many more tools included

By supplying your email you agree to FP Markets privacy policy and receive future marketing materials from FP Markets. You can unsubscribe at any time.





Get instant Updates in Telegram
Sitemap | © FP Markets 2022